Research Article
Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma
Figure 6
The expression of immune regulatory genes in the low- and high-risk groups. The expression differences in immune-related chemokines (a), immunosuppressants (b), immune-stimulating factors (c), and immune receptor genes (d) between the high- and low-risk groups. , , and .
(a) |
(b) |
(c) |
(d) |